v3.26.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2026
Dec. 31, 2025
Assets    
Cash and cash equivalents $ 797 $ 420
Accounts receivable, net of allowance for credit losses of $27 and $25 as of September 30, 2026 and December 31, 2025, respectively 1,712 1,408
Inventories 218 189
Prepaid expenses and other current assets 390 361
Total current assets 3,117 2,378
Property, plant and equipment, net 2,275 2,203
Operating lease right-of-use assets 670 657
Goodwill 9,112 8,945
Intangible assets, net 1,634 1,636
Investments in equity method investees 139 136
Other assets 274 270
Total assets 17,221 16,225
Current liabilities:    
Accounts payable and accrued expenses 1,643 1,600
Less: Current portion of long-term debt 10 504
Current portion of long-term operating lease liabilities 181 174
Total current liabilities 1,834 2,278
Long-term debt 5,540 5,167
Long-term operating lease liabilities 554 537
Other liabilities 1,262 957
Commitments and contingencies
Redeemable noncontrolling interest 81 80
Quest Diagnostics stockholders’ equity:    
Common stock, par value $0.01 per share; 600 shares authorized as of both September 30, 2026 and December 31, 2025; 162 shares issued as of both September 30, 2026 and December 31, 2025 2 2
Additional paid-in capital 2,397 2,381
Retained earnings 10,593 9,994
Accumulated other comprehensive loss (66) (27)
Treasury stock, at cost; 52 shares as of both September 30, 2026 and December 31, 2025 (5,294) (5,180)
Total Quest Diagnostics stockholders’ equity 7,632 7,170
Noncontrolling interests 318 36
Total stockholders’ equity 7,950 7,206
Total liabilities and stockholders’ equity $ 17,221 $ 16,225